Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol. 2019;167:231–55.

Article  PubMed  Google Scholar 

Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222–34.

Article  PubMed  PubMed Central  Google Scholar 

Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei P, Ayton S, Bush AI. The essential elements of Alzheimer’s disease. J Biol Chem. 2021;296:100105.

Article  CAS  PubMed  Google Scholar 

Ferrari C, Sorbi S. The complexity of Alzheimer’s disease: an evolving puzzle. Physiol Rev. 2021;101(3):1047–81.

Article  CAS  PubMed  Google Scholar 

Breijyeh Z, Karaman R. Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules. 2020;25(24):5789.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Curr Neuropharmacol. 2020;18(11):1106–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatulian SA. Challenges and hopes for Alzheimer’s disease. Drug Discov Today. 2022;27(4):1027–43.

Article  PubMed  Google Scholar 

Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer’s disease. Neurosci Lett. 2019;705:183–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo C, Jeong HH, Hsieh YC, Klein HU, Bennett DA, De Jager PL, et al. Tau activates transposable elements in Alzheimer’s disease. Cell Rep. 2018;23(10):2874–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenberg PB, Lyketsos CG. New clues to preclinical Alzheimer’s disease. Am J Psychiatry. 2018;175(6):493–4.

Article  PubMed  Google Scholar 

Masoumi J, Abbasloui M, Parvan R, Mohammadnejad D, Pavon-Djavid G, Barzegari A, et al. Apelin, a promising target for Alzheimer disease prevention and treatment. Neuropeptides. 2018;70:76–86.

Article  CAS  PubMed  Google Scholar 

Huo Z, Yu L, Yang J, Zhu Y, Bennett DA, Zhao J. Brain and blood metabolome for Alzheimer’s dementia: findings from a targeted metabolomics analysis. Neurobiol Aging. 2020;86:123–33.

Article  CAS  PubMed  Google Scholar 

Maszka P, Kwasniak-Butowska M, Cysewski D, Slawek J, Smolenski RT, Tomczyk M. Metabolomic footprint of disrupted energetics and amino acid metabolism in neurodegenerative diseases: perspectives for early diagnosis and monitoring of therapy. Metabolites. 2023;13(3):369.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grao-Cruces E, Claro-Cala CM, Montserrat-de la Paz S, Nobrega C. Lipoprotein metabolism, protein aggregation, and Alzheimer’s disease: a literature review. Int J Mol Sci. 2023;24(3):2944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS. Cardiolipin, mitochondria, and neurological disease. Trends Endocrinol Metab. 2021;32(4):224–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe Y, Hirao Y, Kasuga K, Tokutake T, Kitamura K, Niida S, et al. Urinary apolipoprotein C3 is a potential biomarker for Alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2020;10(3):94–104.

Article  PubMed  PubMed Central  Google Scholar 

Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer’s disease. Int J Mol Sci. 2020;21(4):1505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wood WG, Schroeder F, Igbavboa U, Avdulov NA, Chochina SV. Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol Aging. 2002;23(5):685–94.

Article  CAS  PubMed  Google Scholar 

Makki BE, Rahman S. Alzheimer’s disease in diabetic patients: a lipidomic prospect. Neuroscience. 2023;530:79–94.

Article  PubMed  Google Scholar 

Pera M, Larrea D, Guardia-Laguarta C, Montesinos J, Velasco KR, Agrawal RR, et al. Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J. 2017;36(22):3356–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pera M, Montesinos J, Larrea D, Agrawal RR, Velasco KR, Stavrovskaya IG, et al. MAM and C99, key players in the pathogenesis of Alzheimer’s disease. Int Rev Neurobiol. 2020;154:235–78.

Article  CAS  PubMed  Google Scholar 

Zang F, Zhu Y, Liu X, Fan D, Wang Q, Zhang Q, et al. Polygenic effects of the lipid metabolic pathway accelerated pathological changes and disrupted default mode network trajectory across the Alzheimer’s disease spectrum. J Clin Psychiatry. 2021;82(6):20m13739.

Article  PubMed  Google Scholar 

Walter J, van Echten-Deckert G. Cross-talk of membrane lipids and Alzheimer-related proteins. Mol Neurodegener. 2013;8:34.

Article  PubMed  PubMed Central  Google Scholar 

Rostagno AA. Pathogenesis of Alzheimer’s disease. Int J Mol Sci. 2022;24(1):107.

Article  PubMed  PubMed Central  Google Scholar 

Sun BL, Li WW, Zhu C, Jin WS, Zeng F, Liu YH, et al. Clinical research on Alzheimer’s disease: progress and perspectives. Neurosci Bull. 2018;34(6):1111–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song M, Jung H, Lee S, Kim D, Ahn M. Diagnostic classification and biomarker identification of Alzheimer’s disease with random forest algorithm. Brain Sci. 2021;11(4):453.

Article  PubMed  PubMed Central  Google Scholar 

Chang CH, Lin CH, Lane HY. Machine learning and novel biomarkers for the diagnosis of Alzheimer’s disease. Int J Mol Sci. 2021;22(5):2761.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speiser JL, Miller ME, Tooze J, Ip E. A comparison of random forest variable selection methods for classification prediction modeling. Expert Syst Appl. 2019;134:93–101.

Article  PubMed  PubMed Central  Google Scholar 

Velazquez M, Lee Y. Random forest model for feature-based Alzheimer’s disease conversion prediction from early mild cognitive impairment subjects. PLoS ONE. 2021;16(4):e0244773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakapraves S, Warzecha M, Mustoe CL, Srirambhatla V, Florence AJ. Prediction of mefenamic acid crystal shape by random forest classification. Pharm Res. 2022;39(12):3099–111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan H, Xie Q, Zhang Z, Wang J, Chen X, Qiu P. Chronological age prediction: developmental evaluation of DNA methylation-based machine learning models. Front Bioeng Biotechnol. 2021;9:819991.

Article  PubMed  Google Scholar 

Pellegrino E, Jacques C, Beaufils N, Nanni I, Carlioz A, Metellus P, et al. Machine learning random forest for predicting oncosomatic variant NGS analysis. Sci Rep. 2021;11(1):21820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

She J, Su D, Diao R, Wang L. A joint model of random forest and artificial neural network for the diagnosis of endometriosis. Front Genet. 2022;13:848116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hason L, Krishnan S. Spontaneous speech feature analysis for Alzheimer’s disease screening using a random forest classifier. Front Digit Health. 2022;4:901419.

Article  PubMed  PubMed Central  Google Scholar 

Moore PJ, Lyons TJ, Gallacher J. Random forest prediction of Alzheimer’s disease using pairwise selection from time series data. PLoS ONE. 2019;14(2):e0211558.